Pages that link to "Q40809470"

The following pages link to Antibody 17b binding at the coreceptor site weakens the kinetics of the interaction of envelope glycoprotein gp120 with CD4. (Q40809470):

Displaying 36 items.

• Global shape and ligand binding efficiency of the HIV-1-neutralizing antibodies differ from those of antibodies that cannot neutralize HIV-1 (Q28250040) (← links)
• A Cinnamon-Derived Procyanidin Compound Displays Anti-HIV-1 Activity by Blocking Heparan Sulfate- and Co-Receptor- Binding Sites on gp120 and Reverses T Cell Exhaustion via Impeding Tim-3 and PD-1 Upregulation (Q28553032) (← links)
• DC-SIGN increases the affinity of HIV-1 envelope glycoprotein interaction with CD4. (Q30472149) (← links)
• Neutralization sensitivity of HIV-1 subtype B' clinical isolates from former plasma donors in China (Q30537665) (← links)
• A single-residue change in the HIV-1 V3 loop associated with maraviroc resistance impairs CCR5 binding affinity while increasing replicative capacity. (Q30654651) (← links)
• A novel human antibody against human immunodeficiency virus type 1 gp120 is V1, V2, and V3 loop dependent and helps delimit the epitope of the broadly neutralizing antibody immunoglobulin G1 b12. (Q31143293) (← links)
• B cell recognition of the conserved HIV-1 co-receptor binding site is altered by endogenous primate CD4. (Q33373664) (← links)
• Soluble CD4 and CD4-mimetic compounds inhibit HIV-1 infection by induction of a short-lived activated state (Q33426352) (← links)
• Characterization of gp120 and its single-chain derivatives, gp120-CD4D12 and gp120-M9: implications for targeting the CD4i epitope in human immunodeficiency virus vaccine design (Q33717477) (← links)
• Interaction with CD4 and antibodies to CD4-induced epitopes of the envelope gp120 from a microglial cell-adapted human immunodeficiency virus type 1 isolate (Q33788874) (← links)
• Kinetic rates of antibody binding correlate with neutralization sensitivity of variant simian immunodeficiency virus strains (Q33984358) (← links)
• Envelope deglycosylation enhances antigenicity of HIV-1 gp41 epitopes for both broad neutralizing antibodies and their unmutated ancestor antibodies (Q34016211) (← links)
• Concordant modulation of neutralization resistance and high infectivity of the primary human immunodeficiency virus type 1 MN strain and definition of a potential gp41 binding site in gp120. (Q34461554) (← links)
• The role of antibody polyspecificity and lipid reactivity in binding of broadly neutralizing anti-HIV-1 envelope human monoclonal antibodies 2F5 and 4E10 to glycoprotein 41 membrane proximal envelope epitopes (Q34610233) (← links)
• Spying on HIV with SPR. (Q35089512) (← links)
• The HIV-1 envelope glycoprotein gp120 features four heparan sulfate binding domains, including the co-receptor binding site. (Q35674470) (← links)
• Stability of a receptor-binding active human immunodeficiency virus type 1 recombinant gp140 trimer conferred by intermonomer disulfide bonding of the V3 loop: differential effects of protein disulfide isomerase on CD4 and coreceptor binding (Q35857416) (← links)
• PGV04, an HIV-1 gp120 CD4 binding site antibody, is broad and potent in neutralization but does not induce conformational changes characteristic of CD4. (Q35868102) (← links)
• Biochemical and genetic characterizations of a novel human immunodeficiency virus type 1 inhibitor that blocks gp120-CD4 interactions (Q36525116) (← links)
• Nef Proteins from HIV-1 Elite Controllers Are Inefficient at Preventing Antibody-Dependent Cellular Cytotoxicity (Q36736588) (← links)
• Antigenicity and immunogenicity of transmitted/founder, consensus, and chronic envelope glycoproteins of human immunodeficiency virus type 1 (Q36760169) (← links)
• HLA class II genes modulate vaccine-induced antibody responses to affect HIV-1 acquisition (Q37013490) (← links)
• Characterization of the outer domain of the gp120 glycoprotein from human immunodeficiency virus type 1 (Q37596552) (← links)
• Flow virometric sorting and analysis of HIV quasispecies from plasma (Q37646885) (← links)
• Antigenicity and immunogenicity of a synthetic human immunodeficiency virus type 1 group m consensus envelope glycoprotein (Q37742876) (← links)
• Surface plasmon resonance for vaccine design and efficacy studies: recent applications and future trends. (Q37762275) (← links)
• Restraining the conformation of HIV-1 gp120 by removing a flexible loop (Q38774625) (← links)
• Bioinformatic analysis of neurotropic HIV envelope sequences identifies polymorphisms in the gp120 bridging sheet that increase macrophage-tropism through enhanced interactions with CCR5. (Q39240591) (← links)
• Influence of the Envelope gp120 Phe 43 Cavity on HIV-1 Sensitivity to Antibody-Dependent Cell-Mediated Cytotoxicity Responses (Q40366464) (← links)
• An HIV-1 Env-Antibody Complex Focuses Antibody Responses to Conserved Neutralizing Epitopes. (Q40463159) (← links)
• Interactions of peptide triazole thiols with Env gp120 induce irreversible breakdown and inactivation of HIV-1 virions (Q41846910) (← links)
• HIV-1 gp120 and Modified Vaccinia Virus Ankara (MVA) gp140 Boost Immunogens Increase Immunogenicity of a DNA/MVA HIV-1 Vaccine (Q41918753) (← links)
• Non-neutralizing Antibodies Targeting the V1V2 Domain of HIV Exhibit Strong Antibody-Dependent Cell-mediated Cytotoxic Activity. (Q41924059) (← links)
• Expression, purification, and characterization of recombinant HIV gp140. The gp41 ectodomain of HIV or simian immunodeficiency virus is sufficient to maintain the retroviral envelope glycoprotein as a trimer (Q45736020) (← links)
• HIV-1 specific IgA Monoclonal Antibodies from an HIV-1 Vaccinee Mediate Galcer Blocking and Phagocytosis (Q47555844) (← links)
• CCR5 structural plasticity shapes HIV-1 phenotypic properties (Q60046351) (← links)